Month: May 2024

AB Amber Grid Operating Results for the 1st Quarter of 2024

Written by Customer Service on May 10, 2024. Posted in Public Companies.

AB Amber Grid, legal entity code: 303090867. Address: Laisvės ave. 10, LT-04215 Vilnius, Lithuania. Amber Grid delivers results for the 1st quarter of 2024 prepared according to the International Financial Reporting Standards: • Revenue for the 1st quarter of 2024 EUR 20.6 million (the 1st quarter of 2023 EUR 25.5 million);• Net profit for the 1st quarter of 2024 EUR 4.0 million (the 1st quarter of 2023 EUR 1.8 million);• EBITDA (earnings before interest, taxes, depreciation and amortisation) for the 1st quarter of 2024 EUR 9.0 million (the 1st quarter of 2023 EUR 5.4 million);• Average return on equity (ROE) for the last 12 month as of 31 March 2024 8.3% (as of 31 March 2023 6.8%). Amber Grid adjusted financial indicators for the 1st quarter of 2024: • Adjusted net profit for the 1st quarter of 2024 EUR 3.4 million (the 1st quarter of...

Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation

Written by Customer Service on May 10, 2024. Posted in Public Companies.

92% (12/13) overall response rate (ORR) for relapsed/refractory AL Amyloidosis patients enrolled in NEXICART-1:12 out of 12 patients not exposed to prior BCMA-targeted bispecific responded to NXC-201 (100% ORR), of which 9 out of 12 were complete responders (75% CRs)1 patient with prior exposure to BCMA-targeted bispecific treatment did not respondBest responder duration of response was 28.0 months with response ongoing as of May 10, 2024 U.S. prevalence of relapsed/refractory AL Amyloidosis is growing 12% per year according to Staron, et al Blood Cancer Journal, estimated to reach 33,277 patients in 2024LOS ANGELES, May 10, 2024 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced...

Lincoln Tech Expands its Partnership with the Peterbilt Technician Institute Offering Specialized Training at its Denver Campus

Written by Customer Service on May 10, 2024. Posted in Public Companies.

Parsippany, NJ, May 10, 2024 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training for more than 75 years, has expanded its training partnership with Peterbilt Motors Company to offer specialized diesel technician training at its Denver, CO campus. The Peterbilt Technician Institute (PTI) at Lincoln Tech will assist Lincoln graduates in building additional skills for Peterbilt-specific equipment and technologies, and in starting new careers at Peterbilt locations across the country. This is the second Lincoln Tech location to offer PTI training; the program was introduced at Lincoln’s Nashville, TN campus last spring. “We’re excited to be able to expand our relationship with Peterbilt to the Denver campus,” says Susan English, Lincoln Tech’s Senior Vice President...

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Written by Customer Service on May 10, 2024. Posted in Earnings Releases And Operating Results.

WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2024, and recent corporate updates. James F. Oliviero, President and Chief Executive Officer of Checkpoint, said, “Over the past few months, we have worked closely with our third-party contract manufacturing organization (“CMO”) for cosibelimab to resolve their inspection deficiencies noted in the complete response letter (“CRL”) we received from the U.S. Food and Drug Administration (“FDA”) last December. Recently, our CMO submitted to FDA their response to the inspection deficiencies, which we believe could allow for the resubmission of our biologics license application (“BLA”). We plan...

Global Ship Lease Declares Quarterly Dividend per Common Share for First Quarter of 2024

Written by Customer Service on May 10, 2024. Posted in Dividend Reports And Estimates.

ATHENS, Greece, May 10, 2024 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced today that the Company’s Board of Directors has declared a dividend of $0.375 per Class A common share for the first quarter of 2024, to be paid on June 3, 2024 to shareholders of record as of May 24, 2024. About Global Ship Lease Global Ship Lease is a leading independent owner of containerships with a diversified fleet of mid-sized and smaller containerships. Incorporated in the Marshall Islands, Global Ship Lease commenced operations in December 2007 with a business of owning and chartering out containerships under fixed-rate charters to top tier container liner companies. It was listed on the New York Stock Exchange in August 2008. As at December 31, 2023, Global Ship Lease owned 68 containerships,...

Regarding the election of the Chairman of the Board of Amber Grid

Written by Customer Service on May 10, 2024. Posted in Public Companies.

AB Amber Grid, legal entity code: 303090867. Address: Laisvės ave. 10, LT-04215 Vilnius, Lithuania. On the 10th of May, 2024 at the Board meeting of Amber Grid, Paulius Butkus, Head of Development and Innovation at EPSO-G, was elected as the Chairman of the Board of Amber Grid. More information:Laura Šebekienė, Head of Communications of Amber Grid,Ph. +370 699 61 246, e-mail: l.sebekiene@ambergrid.ltAttachmentPaulius Butkus elected as a Chairman of the Board of Amber Grid

Litgrid AB results for the three months of 2024

Written by Customer Service on May 10, 2024. Posted in Public Companies.

Lithuanian electricity transmission system operator LITGRID AB (company code 302564383, registered office address Karlo Gustavo Emilio Manerheimo str. 8, Vilnius, Lithuania) is publishing results of the Company for the three months of 2024.Main financial indicators Q1 2024 Q1 2023Revenue, EUR million 113.0 86.8EBITDA, EUR million 29.4 19.7Net profit, EUR million 21.5 12.9ROE (for the last 12 months), percents 25.9 -17,3Adjusted* EBITDA, EUR million 12.8 9.4Adjusted* Net profit, EUR million 7.4 4.0Adjusted* ROE (for the last 12 months), percents 11.5 6.0*The adjustment of income, costs and profitability indicators is carried out due to temporary regulatory difference from the regulated profitability approved by NERC. The indicators are adjusted by the correction...

Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th

Written by Customer Service on May 10, 2024. Posted in Public Companies.

SOLANA BEACH, Calif., May 10, 2024 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological conditions, today announced that it will be participating in the 2024 Pharma Partnering Summit being held May 14th – 15th in San Diego, California. Gregory D. Gorgas, President and Chief Executive Officer of Artelo, is scheduled to present on Tuesday, May 14, 2024, at 3:45 p.m. ET / 12:45 p.m. PT. Management will also be hosting meetings with potential partners throughout the summit. The Pharma Partnering Summit 2024 is an exclusive and one of the most prestigious life sciences deal making international conferences. The platform brings together senior executives...

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

Written by Customer Service on May 10, 2024. Posted in Public Companies.

NEWTOWN, Pa., May 10, 2024 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its first quarter 2024 financial results on Monday, May 13, 2024, after the market closes. Dane C. Andreeff, President and Chief Executive Officer, and Jeffrey S. Mathiesen, Chief Financial Officer will host a conference call to discuss the results and provide an expanded business update regarding Helius’ progress and plans surrounding the U.S. commercialization of PoNS® as follows:Date: Monday, May 13, 2024Time: 4:30 p.m. Eastern TimeRegister (Audio only): Click HereWebcast: Click Here The webcast will be archived...

L.B. Foster Company Board of Directors Awarded ‘Public Company Board of the Year’

Written by Customer Service on May 10, 2024. Posted in Public Companies.

PITTSBURGH, May 10, 2024 (GLOBE NEWSWIRE) — L.B. Foster Company (Nasdaq: FSTR), a global technology solutions provider of products and services for the rail and infrastructure markets, today announced its Board of Directors has been recognized as the “Public Company Board of the Year” by the National Association of Corporate Directors (NACD) Three Rivers Chapter. The annual Director of the Year Awards for the Three Rivers Chapter, which covers the Pittsburgh, PA, Buffalo, NY, and Cleveland and Cincinnati, OH, areas, honors company boards and directors in the public, private, and non-profit sectors for their achievements. Raymond T. Betler, Chairman of the L.B. Foster Board, commented, “I joined the board at a time of necessary change in 2020. We moved forward with a small, collaborative team consisting of Board of Directors members...

Month: May 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals